首页|乙酰半胱氨酸颗粒在健康受试者中的生物等效性研究

乙酰半胱氨酸颗粒在健康受试者中的生物等效性研究

扫码查看
本研究旨在评估中国健康受试者中,国产自研乙酰半胱氨酸颗粒(T)与国外原研制剂(R)在空腹和餐后状态下的生物等效性.采用单次给药、两周期、两序列交叉试验设计,72 名健康受试者参与.通过检测血浆中乙酰半胱氨酸浓度,并计算主要药代动力学参数,结果显示T和R在空腹和餐后状态下的Cmax、AUC0-t、AUC0-∞几何均值比的 90%置信区间均满足生物等效性标准.结果表明在中国健康受试者中,T和 R在空腹和餐后状态下均生物等效且安全,可互换使用.
Bioequivalence study of acetylcysteine granules in healthy subjects
The aim of this study was to evaluate the bioequivalence of domestically developed acetylcysteine granules(T)versus the foreign original developer(R)in fasting and postprandial states in healthy Chinese subjects.The study involved 72 healthy subjects,and designed single-dose,two-period,two-sequence crossover trial.By measuring plasma concentrations of acetylcysteine and calculating the main pharmacokinetic parameters,the results showed that the 90%confidence intervals for the geometric mean ratios of Cmax,AUC0-τ,and AUC0-∞ between T and R under both fasting and postprandial conditions met the bioequivalence criteria.Therefore,it was concluded that T and R were bioequivalent and safe in Chinese healthy subjects under both fasting and postprandial conditions,and could be used interchangeably.

pharmacologyacetylcysteine granulespharmacokineticsbioequivalence

康静粉、许博灿、眭紫薇、刘洋

展开 >

河北龙海药业有限公司,石家庄市口服速释制剂产业技术研究院,石家庄 052165

河北科海医药科技有限公司,石家庄 052165

药理学 乙酰半胱氨酸颗粒 药代动力学 生物等效性

河北省科技厅河北省创新能力提升计划项目

225A2702D

2024

中国科技论文在线精品论文
教育部科技发展中心

中国科技论文在线精品论文

ISSN:1674-2850
年,卷(期):2024.17(3)